1 Dividend to Buy, 1 Dividend to Sell

The following video is part of our "Motley Fool Conversations" series, in which Andrew Tonner, technology editor and analyst, and David Williamson, health-care editor and analyst, discuss topics across the investing world.

In today's edition, they continue their series of one dividend to buy and one dividend to sell in 2012. Andrew discusses consulting firm Computer Sciences, and David talks about AstraZeneca.

If you're interested in Computer Sciences or AstraZeneca on your quest for great dividend-paying stocks, The Motley Fool has compiled a special FREE report outlining our 11 favorite, dependable, dividend-paying stocks. It's called "Secure Your Future With 11 Rock-Solid Dividend Stocks." You can access your complimentary copy today at no cost! Just click here to discover the winners we've picked.

At the time thisarticle was published Andrew Tonner does not own shares of the companies listed above. David Williamson owns shares of Pfizer.Motley Fool newsletter serviceshave recommended buying shares of Pfizer. Try any of our Foolish newsletter servicesfree for 30 days. We Fools may not all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. The Motley Fool has adisclosure policy.

Copyright © 1995 - 2011 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.